Navoximod

Item number	Size	Delivery time	Price
TGM-TQ0071-1mg	1 mg	5 - 10 business days*	152.00€
TGM-TQ0071-5mg	5 mg	5 - 10 business days*	327.00€
TGM-TQ0071-1mL	1 ml	5 - 10 business days*	333.00€
TGM-TQ0071-10mg	10 mg	5 - 10 business days*	493.00€
TGM-TQ0071-25mg	25 mg	5 - 10 business days*	631.00€
TGM-TQ0071-50mg	50 mg	5 - 10 business days*	784.00€
TGM-TQ0071-100mg	100 mg	5 - 10 business days*	1,099.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Navoximod (GDC-0919) (NLG- 919, GDC-0919) is a potent indoleamine-(2,3)-dioxygenase... more

Close menu

Product information "Navoximod"

Description: Navoximod (GDC-0919) (NLG- 919, GDC-0919) is a potent indoleamine-(2,3)-dioxygenase (IDO) pathway inhibitor (Ki/EC50: 7 nM/75 nM). Target: Indoleamine 2,3-Dioxygenase (IDO). Smiles: [H][C@@]1(CC[C@H](O)CC1)[C@H](O)C[C@H]1c2c(cccc2F)-c2cncn12. References: Mario R. Mautino, et al. Abstract 491: NLG919, a novel indoleamine-2,3-dioxygenase (IDO)-pathway inhibitor drug candidate for cancer therapy. AACR 104th Annual Meeting 2013, Apr 6-10, 2013.

Keywords:	GDC-0919, NLG-919
Supplier:	TargetMol
Supplier-Nr:	TQ0071

Properties

Application:	Targets indoleamine 2,3-dioxygenase [EC:1.13.11.52] (IDO, INDO)
MW:	316.37 D
Formula:	C18H21FN2O2

Database Information

CAS :	1402837-78-8\| Matching products
KEGG ID :	K00463 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Navoximod"

Write a review